ATYPICAL PARKINSONISM

Clinical trials for ATYPICAL PARKINSONISM explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL PARKINSONISM trials appear

Sign up with your email to follow new studies for ATYPICAL PARKINSONISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Hope for PSP: new drug AMX0035 tested in major trial

Disease control Completed

This study tested an experimental drug called AMX0035 in 139 people with progressive supranuclear palsy (PSP), a rare brain disease that affects movement and balance. The goal was to see if the drug could slow down the disease compared to a placebo. Participants took the drug or …

Matched conditions: ATYPICAL PARKINSONISM

Phase: PHASE2, PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 15, 2026 19:02 UTC

ATYPICAL PARKINSONISM

Get alerted when new ATYPICAL PARKINSONISM trials appear

Hope for PSP: new drug AMX0035 tested in major trial